More reports of adverse effects of implants in 2019 In 2019, the Dutch reporting centre for adverse effects of medical implants (MEBI) received 397 reports of suspected adverse effects. The reports concerned 462 implants.
Excess mortality decreasing, now also in nursing- and care homes The actual number of deaths from the novel coronavirus in the Netherlands is higher than the reported numbers that RIVM publishes daily.
COVID-19 in nursing homes It is estimated that about one-third of nursing homes in the Netherlands have at least one patient with COVID-19.
Excess mortality caused by the novel coronavirus (COVID-19) The actual number of deaths from the novel coronavirus in the Netherlands is higher than the reported numbers published by RIVM.
Regional differences in the coronavirus epidemic There are significant regional differences in the coronavirus epidemic in the Netherlands.
Higher mortality during heatwave in July in the Netherlands During the last heatwave, almost 400 more deaths were reported than was expected on overage for that period. The additional deaths mainly concerned persons aged 75 years and older.
Teun van Dillen awarded the Joh Aten Grant 2015 for SUDOQU The Dutch Society for Radiation Protection (NVS) has awarded its Joh Aten Grant 2015 to Teun van Dillen of the Dutch National Institute for Public Health and the Environment (RIVM) for his work on
Measles epidemic and Salmonella outbreak cost nearly six million euros The most recent measles epidemic and outbreak of Salmonella Thomson due to smoked salmon have cost 3.9 and 1.7 million euros, respectively.
European Antibiotic Awareness Day: the fight against antibiotics resistance Wednesday, 18 November is European Antibiotic Awareness Day. On this day, attention throughout Europe is requested for the responsible use of antibiotics in people and animals.
Report The National Immunisation Programme in the Netherlands: surveillance and developments in 2014-2015 Every year, the Dutch National Institute for Public Health and the Environment, RIVM provides an overview of surveillance and developments in the National Immunisation Programme (NIP).